ResMed debuts Mobi

 - 
Tuesday, January 9, 2018

SAN FRANCISCO – ResMed has formally introduced its first portable oxygen concentrator to the market. The company says Mobi will be available to U.S. patients through their HME providers later this quarter, and it is pursuing clearance to sell in other countries in 2018. “We have focused decades of patient-centered ResMed technology and design innovation into this POC," said ResMed CEO Mick Farrell. "We've achieved great mobility, comfort and therapy quality in sleep apnea treatment with AirMini, the world's smallest PAP device. Mobi offers that same great balance to the many millions of people who rely on supplemental oxygen to enjoy their highest quality of life." ResMed technically entered the home oxygen therapy market in 2016 when it bought Austin, Texas-based Inova Technologies, the manufacturer of the LifeChoice Activox, an ultra-light POC, and the Activox DUO2, an integrated stationary and POC system.